285 related articles for article (PubMed ID: 37544646)
1. The PARN, TOE1, and USB1 RNA deadenylases and their roles in non-coding RNA regulation.
Huynh TN; Parker R
J Biol Chem; 2023 Sep; 299(9):105139. PubMed ID: 37544646
[TBL] [Abstract][Full Text] [Related]
2. PARN and TOE1 Constitute a 3' End Maturation Module for Nuclear Non-coding RNAs.
Son A; Park JE; Kim VN
Cell Rep; 2018 Apr; 23(3):888-898. PubMed ID: 29669292
[TBL] [Abstract][Full Text] [Related]
3. PARN Modulates Y RNA Stability and Its 3'-End Formation.
Shukla S; Parker R
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28760775
[TBL] [Abstract][Full Text] [Related]
4. The RNase PARN Controls the Levels of Specific miRNAs that Contribute to p53 Regulation.
Shukla S; Bjerke GA; Muhlrad D; Yi R; Parker R
Mol Cell; 2019 Mar; 73(6):1204-1216.e4. PubMed ID: 30770239
[TBL] [Abstract][Full Text] [Related]
5. Poly(A)-specific ribonuclease (PARN) mediates 3'-end maturation of the telomerase RNA component.
Moon DH; Segal M; Boyraz B; Guinan E; Hofmann I; Cahan P; Tai AK; Agarwal S
Nat Genet; 2015 Dec; 47(12):1482-8. PubMed ID: 26482878
[TBL] [Abstract][Full Text] [Related]
6. TOE1 acts as a 3' exonuclease for telomerase RNA and regulates telomere maintenance.
Deng T; Huang Y; Weng K; Lin S; Li Y; Shi G; Chen Y; Huang J; Liu D; Ma W; Songyang Z
Nucleic Acids Res; 2019 Jan; 47(1):391-405. PubMed ID: 30371886
[TBL] [Abstract][Full Text] [Related]
7. Distinct Poly(A) nucleases have differential impact on sut-2 dependent tauopathy phenotypes.
Kow RL; Strovas TJ; McMillan PJ; Jacobi AM; Behlke MA; Saxton AD; Latimer CS; Keene CD; Kraemer BC
Neurobiol Dis; 2021 Jan; 147():105148. PubMed ID: 33184027
[TBL] [Abstract][Full Text] [Related]
8. Kiss your tail goodbye: the role of PARN, Nocturnin, and Angel deadenylases in mRNA biology.
Godwin AR; Kojima S; Green CB; Wilusz J
Biochim Biophys Acta; 2013; 1829(6-7):571-9. PubMed ID: 23274303
[TBL] [Abstract][Full Text] [Related]
9. Poly(A)-specific ribonuclease and Nocturnin in squamous cell lung cancer: prognostic value and impact on gene expression.
Maragozidis P; Papanastasi E; Scutelnic D; Totomi A; Kokkori I; Zarogiannis SG; Kerenidi T; Gourgoulianis KI; Balatsos NA
Mol Cancer; 2015 Nov; 14():187. PubMed ID: 26541675
[TBL] [Abstract][Full Text] [Related]
10. Translation Efficiency and Degradation of ER-Associated mRNAs Modulated by ER-Anchored poly(A)-Specific Ribonuclease (PARN).
Duan TL; Jiao H; He GJ; Yan YB
Cells; 2020 Jan; 9(1):. PubMed ID: 31936572
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of telomerase RNA decay rescues telomerase deficiency caused by dyskerin or PARN defects.
Shukla S; Schmidt JC; Goldfarb KC; Cech TR; Parker R
Nat Struct Mol Biol; 2016 Apr; 23(4):286-92. PubMed ID: 26950371
[TBL] [Abstract][Full Text] [Related]
12. Incomplete splicing of neutrophil-specific genes affects neutrophil development in a zebrafish model of poikiloderma with neutropenia.
Patil P; Uechi T; Kenmochi N
RNA Biol; 2015; 12(4):426-34. PubMed ID: 25849198
[TBL] [Abstract][Full Text] [Related]
13. PolyA-specific ribonuclease (PARN-1) function in stage-specific mRNA turnover in Trypanosoma brucei.
Utter CJ; Garcia SA; Milone J; Bellofatto V
Eukaryot Cell; 2011 Sep; 10(9):1230-40. PubMed ID: 21743004
[TBL] [Abstract][Full Text] [Related]
14. Poly(A)-specific ribonuclease (PARN): an allosterically regulated, processive and mRNA cap-interacting deadenylase.
Virtanen A; Henriksson N; Nilsson P; Nissbeck M
Crit Rev Biochem Mol Biol; 2013; 48(2):192-209. PubMed ID: 23496118
[TBL] [Abstract][Full Text] [Related]
15. Biallelic mutations in the 3' exonuclease TOE1 cause pontocerebellar hypoplasia and uncover a role in snRNA processing.
Lardelli RM; Schaffer AE; Eggens VR; Zaki MS; Grainger S; Sathe S; Van Nostrand EL; Schlachetzki Z; Rosti B; Akizu N; Scott E; Silhavy JL; Heckman LD; Rosti RO; Dikoglu E; Gregor A; Guemez-Gamboa A; Musaev D; Mande R; Widjaja A; Shaw TL; Markmiller S; Marin-Valencia I; Davies JH; de Meirleir L; Kayserili H; Altunoglu U; Freckmann ML; Warwick L; Chitayat D; Blaser S; Çağlayan AO; Bilguvar K; Per H; Fagerberg C; Christesen HT; Kibaek M; Aldinger KA; Manchester D; Matsumoto N; Muramatsu K; Saitsu H; Shiina M; Ogata K; Foulds N; Dobyns WB; Chi NC; Traver D; Spaccini L; Bova SM; Gabriel SB; Gunel M; Valente EM; Nassogne MC; Bennett EJ; Yeo GW; Baas F; Lykke-Andersen J; Gleeson JG
Nat Genet; 2017 Mar; 49(3):457-464. PubMed ID: 28092684
[TBL] [Abstract][Full Text] [Related]
16. Expanding the repertoire of deadenylases.
Skeparnias I; Αnastasakis D; Shaukat AN; Grafanaki K; Stathopoulos C
RNA Biol; 2017 Oct; 14(10):1320-1325. PubMed ID: 28267419
[TBL] [Abstract][Full Text] [Related]
17. Sm complex assembly and 5' cap trimethylation promote selective processing of snRNAs by the 3' exonuclease TOE1.
Ma T; Xiong ES; Lardelli RM; Lykke-Andersen J
Proc Natl Acad Sci U S A; 2024 Jan; 121(3):e2315259121. PubMed ID: 38194449
[TBL] [Abstract][Full Text] [Related]
18. Identification of PARN nuclease activity inhibitors by computational-based docking and high-throughput screening.
Huynh TN; Shukla S; Reigan P; Parker R
Sci Rep; 2023 Mar; 13(1):5244. PubMed ID: 37002320
[TBL] [Abstract][Full Text] [Related]
19. Competition between maturation and degradation drives human snRNA 3' end quality control.
Lardelli RM; Lykke-Andersen J
Genes Dev; 2020 Jul; 34(13-14):989-1001. PubMed ID: 32499401
[TBL] [Abstract][Full Text] [Related]
20. Modulation of poly(A)-specific ribonuclease (PARN): current knowledge and perspectives.
Balatsos NA; Maragozidis P; Anastasakis D; Stathopoulos C
Curr Med Chem; 2012; 19(28):4838-49. PubMed ID: 22834816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
